Aurobindo Pharma has said that it has received the US health administratorâ€™s approval for Lopinavir/Ritonavir tablets used in the treatment of HIV infections. In a filing to the Bombay Stock Exchange, the pharma company said it has received approval from US Food and Drug Administration (USFDA) for tablets that are in the strength of 100/25 mg and 200/50 mg. Lopinavir/Ritonavir tablets are used in the treatment of HIV infection in adults and children above the age of two years, the filing added. Aurobindo now has a total of 93 abbreviated new drug application (ANDA) approvals from USFDA.
Every time an offender stealthily leaves India to take refuge in another country, the Government of India starts all over again with its strategy of bringing him back to the nation to make him stan More
Helplinelaw can set up your session with quality and experienced lawyers to discuss and resolve your legal matters. You can avail consultation in form of sending questions, phone call or webchat discussion More